. Author manuscript; available in PMC: 2013 Dec 9.

Published in final edited form as: Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):10.1152/ajpgi.00011.2006. doi: 10.1152/ajpgi.00011.2006

Table 1.

Body weights, relative organ weights, and plasma retinol concentrations in RA- and LPS-treated rats

	Control	RA	LPS	RA + LPS
BW at dosing, g	233.8±9.80	224.2±8.67	212.9±5.74	217.9±7.36
Change in BW, g/12 h	−6.8±1.0	−6.4±0.9	−8.0±1.0	−8.2±1.0
Liver weight, % BW	3.64±0.06	3.76±0.12	3.91±0.11	4.03±0.10^a
Lung weight, % BW	0.51±0.02	0.53±0.01	0.54±0.02	0.53±0.02
Spleen weight, % BW	0.22±0.01	0.22±0.01	0.27±0.01^a,^b	0.29±0.01^a,^b
Small intestine weight, % BW	2.29±0.09	2.41±0.09	2.43±0.13	2.43±0.14
Plasma retinol, µmol/l	0.54±0.06	0.44±0.06	0.30±0.04^a,^b	0.29±0.04^a,^b
Liver total retinol, nmol/g^*	17±11	21±6	18±5	14±17
Total ³H-labeled retinoids, % ID^†	30.0±1.23	33.3±1.38	26.5±1.16^b	28.1±1.15^b

Values are means ± SE; n = 9/group. RA, retinoic acid; LPS, lipopolysaccharide; BW, body wt.

For liver total retinol, values are means ± range of two representative rats per group.

^†

For total ³H-labeled retinoids, values are sums of plasma, liver, lung, and small intestine total ³H-labeled retinoids, expressed as percent injected dose (ID).

Statistically different from control rats (P < 0.05).

Statistically different from RA-treated rats (P < 0.05).